Amanote Research

Amanote Research

    RegisterSign In

Ibrutinib Inhibits SDF1/CXCR4 Mediated Migration in AML

Oncotarget - United States
doi 10.18632/oncotarget.2479
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

September 16, 2014

Authors
Lyubov ZaitsevaMegan Y. MurrayManar S. ShafatMatthew J. LawesDavid J. MacEwanKristian M. BowlesStuart A. Rushworth
Publisher

Impact Journals, LLC


Related search

Chloroquine-Containing HPMA Copolymers as Polymeric Inhibitors of Cancer Cell Migration Mediated by the CXCR4/SDF1 Chemokine Axis

English

The SDF1-CXCR4-axis in HPV-positive and HPV-negative HNSCC

2018English

RIG-I Inhibits SRC-Mediated AKT/mTOR Signaling and Stemness in AML

Cancer Discovery
Oncology
2014English

Ibrutinib Also Inhibits ITK

Cancer Discovery
Oncology
2013English

Blocking CXCR4-Mediated Cyclic AMP Suppression Inhibits Brain Tumor Growth in Vivo

Cancer Research
Cancer ResearchOncology
2007English

Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL--Letter

Clinical Cancer Research
Cancer ResearchOncology
2016English

During Tangential Migration, SDF1 Lends the Cytoskeleton a Guiding Hand

Journal of Neuroscience
Neuroscience
2014English

SDF1/CXCR4 Contributes to Neural Regeneration in Hemiplegic Mice With a Monkey ES-cell-derived Neural Graft

Inflammation and Regeneration
AllergyImmunology
2010English

Macrophage Migration Inhibitory Factor-Cxcr4 Receptor Interactions

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy